Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 790
Guide Official Revision Description Reason for Update
Version Date Number Of Change
Cushing’s Syndrome
Disposition Table.
2025 09/24/2025 6. Administrative In Item 48. General
Systemic, revised Endocrine
Disorders Disposition Table.
Row for Cushing’s Disease
or Syndrome removed.
2025 09/24/2025 7. Medical Policy In Item 41. G.U., revised
CACI - Low Testosterone
(Low T) hypogonadism CACI
to allow use with history of
cardiovascular disease or
prostate cancer.
2025 09/24/2025 8. Medical Policy In Item 41. G. U., updated
Low Testosterone (Low T)
Hypogonadism Status
Summary to remove
cardiovascular disease and
prostate cancer.
2025 09/24/2025 9. Medical Policy In Special Issuances, revised
Low Testosterone
(Low T) Hypogonadism
AASI. Removed
cardiovascular disease and
prostate cancer; defer if
hematocrit 55 or higher.
2025 09/24/2025 10. Medical Policy In Item 35. Lungs and Chest,
added new Sarcoid
Disposition Table.
2025 09/24/2025 11. Medical Policy In Item 35. Lungs and Chest,
added new Sarcoid Status
Summary.
2025 09/24/2025 12. Administrative In Item 35. Lungs and Chest,
revised Pleura and Pleural
Cavity Disposition Table.
Row for Sarcoid removed.
2025 09/24/2025 13. Administrative In Item 40. Skin, removed
Sarcoid from Cutaneous
Disposition Table.
2025 09/24/2025 14. Medical Policy In
